TFF2 and neoplasm: Furthermore, immunohistofluorescence indicated that the number of TUNEL positive tumor cells in the injected group with AdC7-SP/E1A-ΔE3 was 7.0 fold more than in the group treated with AdC7-ΔE1A-ΔE3(p < 0.0001) (Figure 8B).